Detalhe da pesquisa
1.
Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature.
J Endocrinol Invest
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696125
2.
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC).
Ann Surg Oncol
; 29(6): 3492-3502, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230580
3.
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study.
Ann Oncol
; 32(5): 600-608, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539945
4.
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.
Ann Oncol
; 30(12): 1959-1968, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562758
5.
Effectiveness of Primary Care Interventions Using a Biopsychosocial Approach in Chronic Low Back Pain: A Systematic Review.
Pain Pract
; 19(2): 224-241, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30290052
6.
What treatment in 2017 for inoperable pancreatic cancers?
Ann Oncol
; 28(7): 1473-1483, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28459988
7.
Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma.
Ann Oncol
; 28(11): 2786-2792, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945895
8.
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Ann Oncol
; 27(4): 654-60, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802160
9.
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.
Br J Cancer
; 110(9): 2165-9, 2014 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714745
10.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
ESMO Open
; 8(1): 100777, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36731325
11.
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey.
ESMO Open
; 6(5): 100238, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392104
12.
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort.
ESMO Open
; 6(1): 100032, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33399070
13.
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.
Br J Cancer
; 102(4): 673-7, 2010 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20125159
14.
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.
Cancer Chemother Pharmacol
; 62(4): 673-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172650
15.
Spinal Surgeons' Opinions on Pre- and Postoperative Rehabilitation in Patients Undergoing Lumbar Spinal Fusion Surgery: A Survey-Based Study in the Netherlands and Sweden.
Spine (Phila Pa 1976)
; 43(10): 713-719, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885297
16.
Bone metastases in biliary cancers: A multicenter retrospective survey.
J Bone Oncol
; 12: 33-37, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042924
17.
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
Ann Oncol
; 18(10): 1660-5, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17660490
18.
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen.
Cancer Lett
; 256(1): 25-8, 2007 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17561341
19.
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study.
Cancer Invest
; 25(7): 594-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17852117
20.
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
Cancer Chemother Pharmacol
; 59(3): 361-7, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16807732